[18F]DPA-714
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for [18F]DPA-714, covering 2023-02-21 to 2026-03-06. Get the full timeline:
Most recent: Clinical Trial Update: Study of Neuroinflammation in Multiple Sclerosis by PET-MRI Imaging Using the Radiotracer ([18F]-DPA-714) : a Multicentre Cohort Study (INFLANET) [NA]